Effect of bacterial lipopolysaccharide on endothelin-1 production in human vascular endothelial cells

Journal of Hepatology

Volumn 26, Issue 1, 1997, Pages 81-87

  Ros, Josefa ^a   Leivas, Alberto ^a   Jiménez, Wladimiro ^a   Morales, Manuel ^a   Bosch Marcé, Marta ^a   Arroyo, Vicente ^a   Rivera, Francisco ^a   Rodés, Joan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

big endothelin 1; cirrhosis; endothelin 1; endotoxin; human endothelial cells; LPS

Indexed keywords

ENDOTHELIN 1; ENDOTOXIN;

ARTICLE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CIRRHOSIS; PRIORITY JOURNAL;

EID: 0031017599     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80013-X     Document Type: Article

References (37)

1. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev. 46:1994;325-415.
2. Simonson MS. Endothelins: multifunctional renal peptides. Physiol Rev. 73:1993;375-411.
3. Clària J, Jiménez W, Arroyo V, Castro A, Asbert M, Ros J, Rivera F, Rodés J. Does of endothelin have natriuretic effects in conscious rats with cirrhosis and ascites. Kidney Int. 40:1991;182-187.
4. Hom GJ, touhey B, Rubany GM. Effects of intracoronary administration of endothelin in anesthetized dogs: comparison with Bay k 8644 and U 46619. J Cardiovasc Pharmacol. 19:1992;194-200.
5. Saito Y., Nakao, Mukoyama M., Imura H. Increased plasma endothelin levels in patients with essential hypertension. N Engl J Med. 322:1990;205.
6. Lerman A., Edwards B.S., Hallet J.W., Heublein D.M., Sandberg S.M., Burnett J.C. Circulating and tissue immunoreactivity in advanced atherosclerosis. N Engl J Med. 325:1991;997-1001.
7. Voerman HJ, Stehouwer CDA, Kamp GJ, Schijdel RS, Groeneveld ABJ, Thijs LG. Plasma endothelin levels are increased during septic shock. Crit Care Med. 20:1992;1097-1101.
8. Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K. Plasma endothelin immunoreactivity in plasma of patients with cirrhosis of the liver. N Engl J Med. 327:1992;1774-1778.
9. Asbert M, Ginés A, Ginés P, Jiménez W, Clària J, Saló J, Arroyo V, Rivera F, Rodés J. Circulating levels of endothelin in cirrhosis. Gastroenterology. 104:1993;1485-1491.
10. Arroyo V, Ginés P, Jiménez W, Rodés J. Ascites, renal failure, and electrolyte disorders in cirrhosis. Pathogenesis, diagnosis and treatment. McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J. Oxford Textbook of Clinical Hepatology. 1991;427-470 Oxford University Press, Oxford.
11. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res. 26:1992;48-57.
12. Guarner C., Soriano G., Tomas A., Bulbena O., Novella M.T., Balanzo J., Vilardell F., Mourelle M., Moncada S. Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia. Hepatology. 18:1993;1139-1143.
13. Hewett J.A., Roth R.A. Hepatic and extraheptic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev. 45:1993;381-411.
14. Sugiura M., Inagami T., Kon V. Endotoxin stimulates endothelin release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun. 161:1989;1220-1227.
15. Jaffe E.A., Nachamn R.L., Becker C.G., Minick C.T. Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 52:1973;2745-2756.
16. Chirgwin J.M., Pryzbyla R.J., McDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1978;5294-5299.
17. Inoue A, Yanagisawa M, Takuwa Y, Mitsui Y, Kobayashi M, Masaki T. The human preproendothelin-1 gene. J Biol Chem. 264:1989;14954-14959.
18. Ercolani L, Florence B, Denaro M, Alexander M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem. 263:1988;1535-1541.
19. Plumpton C, Kalinka S, Martin RC, Horton JK, Davenport AP. Effects of phophoramidon and pepstatin A on the secretion of endothelin-1 and big endothelin-1 by human umbilical vein endothelial cells: measurement by two-site enzyme immunosorbent assays. Clin Sci. 87:1994;245-251.
20. Arendt RM, Schmoeckel M, Wilbert-Lampen U, Plasse A, Heucke L, Werdan K. Bidirectional effects of endogenous opioid peptides on endothelin release rates in porcine aortic endothelial cell culture: Mediation by delta opioid receptor and opioid receptor antagonist-insensitive mechanisms. J Pharmacol Exp Ther. 272:1995;1-7.
21. Uchihara M, Izumi N, Sato CH, Marumo F. Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology. 16:1992;95-99.
22. Saló J, Francitorra A, Follo A, Navasa M, Ginès A, Jiménez W, Ginés P, Arroyo V, Rivera F, Rodés J. Increased plasma endothelin in cirrhosis. Relationship with systemic endotoxemia and response to changes in effective blood volume. J Hepatol. 22:1995;389-398.
23. Battistini B, D'Orleans-Juste P, Sirois P. Biology of Disease. Endothelins: Circulating plasma levels and presence in other biologic fluids. Lab Invest. 68:1993;600-628.
24. Pernow J, Hemsen A, Lundberg JM. Increased plasma levels of immunoreactivity during endotoxin administration in the pig. Acta Physiol Scand. 137:1989;317-318.
25. Leivas A, Jiménez W, Lamas S, Bosch-Marcé M, Oriola J, Clària J, Arroyo V, Rivera F, Rodés J. Endothelin-1 does not play a major role in the homeostatis of arterial pressure in cirrhotic rats with ascites. Gastroenterology. 108:1995;1842-1848.
26. Maeda K, Abello PA, Abraham MR, Wetzel RC, Robotham JL, Buchman TG. Endotoxin induces organ-specific cell injury. Shock. 3:1995;46-50.
27. Roth RA, Hewett JA. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev. 45:1993;381-411.
28. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ. Structure and function of lipopolysaccharide binding protein. Science. 249:1990;1429-1431.
29. Wright SD, Ramos A, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1990;1431-1433.
30. Schumann RR, Rietschel ET, Loppnow H. The role of Cd14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin. Med Microbiol Immunol. 183:1994;279-297.
31. Bazil V, Horejsi B, Baudys M, Kristofova H, Strominger JL, Kostka W, Hilgert I. Biochemical characterization of soluble form of the 53-kDa monocyte surface antigen. Eur J Immunol. 16:1986;1583-1589.
32. Patrick D, Betts J, Frey EA, Prameya R, Dorovini-Zis K, Finlay BB. Heamophilus influenzae lipopolysaccharide disrupts confluent monolayers of bovine brain endothelial cells via serum-dependent cytotoxic pathway. J Infect Dis. 165:1992;865-872.
33. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevsik T, Finlay BB, Wright SD. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med. 176:1993;1665-1671.
34. Haziot A, Rong GW, Silver J, Goyert SM. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J Immunol. 151:1993;1500-1507.
35. Morrison DC, Jacobs DM. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry. 13:1976;813-818.
36. Opgenorth TJ, Wu-Wong JR, Shiosaki K. Endothelin-converting enzymes. FASEB J. 6:1992;2653-2659.
37. Harrison VJ, Barnes K, Turner AJ, Wood E, Corder R, Vane JR. Identification of endothelin 1 and big endothelin 1 in secretory vesicles isolated from bovine aortic endothelial cells. Proc Natl Acad Sci USA. 92:1995;6344-6348.